Edition:
United States

Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

2.42USD
3:59pm EST
Change (% chg)

$-0.01 (-0.41%)
Prev Close
$2.43
Open
$2.43
Day's High
$2.64
Day's Low
$2.24
Volume
242,105
Avg. Vol
69,037
52-wk High
$3.67
52-wk Low
$0.88

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.133
Jun '17 0.00 -0.139
Mar '17 0.00 -0.154
FY 2016 Dec '16 0.00 -0.130
Sep '16 0.00 -0.159
Jun '16 0.00 -0.201
Mar '16 0.00 -0.243
FY 2015 Dec '15 0.00 -0.192
Sep '15 0.00 -0.259
Jun '15 0.00 -0.208
Mar '15 0.00 -0.220
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Year Ending Dec-17 3 0.00 0.00 0.00 0.00
Year Ending Dec-18 3 10.00 20.00 0.00 10.00
Earnings (per share)
Quarter Ending Dec-17 3 -0.11 -0.11 -0.12 -0.17
Quarter Ending Mar-18 2 -0.12 -0.06 -0.17 --
Year Ending Dec-17 2 -0.52 -0.52 -0.53 -0.87
Year Ending Dec-18 3 -0.45 -0.25 -0.60 -0.81
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 186.11 35.51
P/E High - Last 5 Yrs. -- 274.30 45.27
P/E Low - Last 5 Yrs. -- 92.17 24.24
Beta 2.57 0.83 0.91
Price to Sales (TTM) -- 113.99 5.83
Price to Book (MRQ) -- 21.50 5.68
Price to Tangible Book (MRQ) 32.44 25.23 7.26
Price to Cash Flow (TTM) -- 101.64 24.44
% Owned Institutions 10.75 5.68 1.39

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.96 5.23
Payout Ratio(TTM) -- 95.86 45.95

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -2.88 6.82
Sales (TTM) vs TTM 1 Yr. Ago -- 30.21 5.65
Sales - 5 Yr. Growth Rate -- 33.15 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 16.42 -147.47 7.23
EPS (TTM) vs TTM 1 Yr. Ago 30.12 -- --
EPS - 5 Yr. Growth Rate -- 43.45 10.90
Capital Spending - 5 Yr. Growth Rate -- 40.96 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.54
Current Ratio (MRQ) 1.62 5.75 3.56
LT Debt to Equity (MRQ) 0.00 14.45 13.23
Total Debt to Equity (MRQ) 0.00 16.90 19.24
Interest Coverage (TTM) -- -147.16 44.55

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.05 54.80
Gross Margin - 5 Yr. Avg. -- 55.37 52.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -219.17 15.52
Operating Margin (TTM) -- -631.99 6.76
Operating Margin - 5 Yr. Avg. -- -236.03 11.03
Pre-Tax Margin (TTM) -- -602.68 7.58
Pre-Tax Margin - 5 Yr. Avg. -- -236.35 11.44
Net Profit Margin (TTM) -- -600.25 3.81
Net Profit Margin - 5 Yr. Avg. -- -239.62 7.73
Effective Tax Rate (TTM) -- 15.32 24.25
Effective Tax Rate - 5 Yr. Avg. -- 18.76 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 21,633,432 858,823,705
Net Income/Employee (TTM) -2,634,857 -1,703,997 100,224,560
Receivable Turnover (TTM) -- 25.40 6.12
Inventory Turnover (TTM) -- 2.62 3.55
Asset Turnover (TTM) 0.00 0.42 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -159.51 -9.13 11.35
Return on Assets - 5 Yr. Avg. -90.24 0.30 12.32
Return on Investment (TTM) -250.97 -11.32 14.47
Return on Investment - 5 Yr. Avg. -102.11 3.50 16.13
Return on Equity (TTM) -- -35.69 16.06
Return on Equity - 5 Yr. Avg. -235.00 5.92 17.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 12.65 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Galectin Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 10.75%
# of Holders: 52
Total Shares Held: 3,831,175
3 Mo. Net Change: -91,628
# New Positions: 5
# Closed Positions: 8
# Increased Positions: 12
# Reduced Positions: 18
# Net Buyers: -6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.